Calix price target raised to $57 from $47 at Rosenblatt

Rosenblatt raised the firm’s price target on Calix to $57 from $47 and keeps a Buy rating on the shares, citing three reasons. The industry looks to be stabilizing, $62B in E-ACAM and BEAD stimulus is “getting closer” and Calix is “an excellent company-specific story,” the analyst tells investors. The firm, which cites Calix’s innovative strategy, higher software revenues over the long-term, and more margin expansion potential than others in the sector, notes that the company is scheduled to report Q4 results on Monday, January 29.